PDF(1772 KB)
Fifty-Year Development History of Recombinant Human Interferon α1b as China’s First Class 1 Innovative Genetically Engineered Drug with Independent Intellectual Property Rights
HOU Yunde, CHENG Yongqing, QIAO Xinran, WU Chen, LIN Fuyu, LIU Jinyi
China Biotechnology ›› 2026, Vol. 46 ›› Issue (9) : 131-141.
PDF(1772 KB)
PDF(1772 KB)
Fifty-Year Development History of Recombinant Human Interferon α1b as China’s First Class 1 Innovative Genetically Engineered Drug with Independent Intellectual Property Rights
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
